Ischemic preconditioning and liver tolerance to warm or cold ischemia: Experimental studies in large animals

Transplantation

Volumn 79, Issue 10, 2005, Pages 1393-1400

  Compagnon, Philippe ^a   Lindell, Susanne ^a   Ametani, Mary S ^a   Gilligan, Barbara ^a   Wang, Hong Bing ^a   D'Alessandro, Anthony M ^a   Southard, James H ^a   Mangino, Martin J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Dogs; Nonheart beating donors; Organ preservation; Transplantation

Indexed keywords

AMINOTRANSFERASE; UNIVERSITY OF WISCONSIN SOLUTION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE FLOW; CONTROLLED STUDY; DOG; ENZYME ACTIVITY; HEART INFARCTION PREVENTION; IMMUNOLOGICAL TOLERANCE; LIVER GRAFT REJECTION; LIVER ISCHEMIA; LIVER PARENCHYMA; LIVER TRANSPLANTATION; NONHUMAN; ORGAN DONOR; ORGAN PRESERVATION; PRIORITY JOURNAL; REPERFUSION INJURY; RISK BENEFIT ANALYSIS; SIGNAL TRANSDUCTION;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CELL SURVIVAL; CRYOPRESERVATION; DOGS; FEMALE; HEAT; HEPATOCYTES; ISCHEMIA; ISCHEMIC PRECONDITIONING; LIVER; LIVER TRANSPLANTATION; ORGAN PRESERVATION; REPERFUSION; REPERFUSION INJURY;

EID: 19544363932     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000164146.21136.0B     Document Type: Article

References (52)

1. Deschenes M, Belle SH, Krom RA, et al. Early allograft dysfunction after liver transplantation: a definition and predictors of outcome. National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Transplantation 1998; 66: 302-310.
2. Strasberg SM, Howard TK, Molmenti EP, et al. Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology 1994; 20: 829-838.
3. Huguet C, Gavelli A, Bona S. Hepatic resection with ischemia of the liver exceeding one hour. J Am Coll Surg 1994; 178: 454-458.
4. Ezaki T, Seo Y, Tomoda H, et al. Partial hepatic resection under intermittent hepatic inflow occlusion in patients with chronic liver disease. Br J Surg 1992; 79: 224-226.
5. Belghiti J, Noun R, Malafosse R, et al. Continuous versus intermittent portal triad clamping for liver resection: a controlled study. Ann Surg 1999; 229: 369-375.
6. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay oflethal cell injury in ischemic myocardium. Circulation 1986; 74: 1124-1136.
7. Toosy N, McMorris EL, Grace PA, et al. Ischaemic preconditioning protects the rat kidney from reperfusion injury. BJU Int 1999; 84: 489-494.
8. Du ZY, Hicks M, Winlaw D, et al. Ischemic preconditioning enhances donor lung preservation in the rat. J Heart Lung Transplant 1996; 15: 1258-1267.
9. Hotter G, Closa D, Prados M, et al. Intestinal preconditioning is mediated by a transient increase in nitric oxide. Biochem Biophys Res Commun 1996; 222: 27-32.
10. Davis JM, Gute DC, Jones S, et al. Ischemic preconditioning prevents postischemic P-selectin expression in the rat small intestine. Am J Physiol 1999; 277; H2476-H2481.
11. Nilsson B, Friman S, Gustafsson BI, et al. Preconditioning protects against ischemia/reperfusion injury of the liver. J Gastrointest Surg 2000; 4: 44-49.
12. Peralta C, Hotter G, Closa D, et al. The protective role of adenosine in inducing nitric oxide synthesis in rat liver ischemia preconditioning is mediated by activation of adenosine A2 receptors. Hepatology 1999; 29: 126-132.
13. Yoshizumi T, Yanaga K, Soejima Y, et al. Amelioration of liver injury by ischaemic preconditioning. Br J Surg 1998; 85: 1636-1640.
14. Hawaleshka A, Jacobsohn E. Ischaemic preconditioning: mechanisms and potential clinical applications. Can J Anaesth 1998; 45: 670-682.
15. Jenkins DP, Baxter GF, Yellon DM. The pathophysiology of ischaemic preconditioning. Pharmacol Res 1995; 31: 219-224.
16. Lloris-Carsi JM, Cejalvo D, Toledo-Pereyra LH, et al. Preconditioning: effect upon lesion modulation in warm liver ischemia. Transplant Proc 1993; 25: 3303-3304.
17. Yadav SS, Sindram D, Perry DK, et al. Ischemic preconditioning protects the mouse liver by inhibition of apoptosis through a caspase-dependent pathway. Hepatology 1999; 30: 1223-1231.
18. Zapletal C, Maksan SM, Lehmann T, et al. Ischemic preconditioning improves liver microcirculation after ischemia/reperfusion. Transplant Proc 1999; 31: 3260-3262.
19. Peralta C, Bartrons R, Riera L, et al. Hepatic preconditioning preserves energy metabolism during sustained ischemia. Am J Physiol Gastrointest Liver Physiol 2000; 279: G163-G171.
20. Yin DP, Sankary HN, Chong AS, et al. Protective effect of ischemic preconditioning on liver preservation-reperfusion injury in rats. Transplantation 1998; 66: 152-157.
21. Arai M, Thurman RG, Lemasters JJ. Contribution of adenosine A(2) receptors and cyclic adenosine monophosphate to protective ischemic preconditioning of sinusoidal endothelial cells against Storage/Reperfusion injury in rat livers. Hepatology 2000; 32: 297-302.
22. Arai M, Thurman RG, Lemasters JJ. Ischemic preconditioning of rat livers against cold storage-reperfusion injury: role of nonparenchymal cells and the phenomenon of heterologous preconditioning. Liver Transpl 2001; 7: 292-299.
23. Adam R, Arnault I, Bao YM, et al. Effect of ischemic preconditioning on hepatic tolerance to cold ischemia in the rat. Transpl Int 1998; 11(suppl 1): S168-S170.
24. Clavien PA, Yadav S, Sindram D, et al. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg 2000; 232: 155-162.
25. Totsuka E, Fung JJ, Urakami A, et al. Influence of donor cardiopulmonary arrest in human liver transplantation: possible role of ischemic preconditioning. Hepatology 2000; 31: 577-580.
26. Schulz R, Walz MK, Behrends M, et al. Minimal protection of the liver by ischemic preconditioning in pigs. Am J Physiol Heart Circ Physiol 2001; 280: H198-H207.
27. Compagnon P, Wang H, Lindell SL, et al. Brain death does not affect hepatic allograft function and survival after orthotopic transplantation in a canine model. Transplantation 2002; 73: 1218-1227.
28. Pienaar BH, Lindell SL, Van Gulik T, et al. Revised method of orthotopic hepatic transplantation in canines. Surg Gynecol Obstet 1989; 169: 341-346.
29. Compagnon P, Wang HB, Southard JH, et al. Ischemic preconditioning in a rodent hepatocyte model of liver hypothermic preservation injury. Cryobiology 2002; 44: 269-278.
30. Mangino JE, Kotadia B, Mangino MJ. Characterization of hypothermic intestinal ischemia-reperfusion injury in dogs. Effects of glycine. Transplantation 1996; 62: 173-178.
31. Sawaya DE Jr, Brown M, Minardi A, et al. The role of ischemic preconditioning in the recruitment of rolling and adherent leukocytes in hepatic venules after ischemia/reperfusion. J Surg Res 1999; 85: 163-170.
32. Kosieradzki M, Ametani M, Southard JH, et al. Is ischemic preconditioning of the kidney clinically relevant? Surgery 2003; 133: 81-90.
33. Fung JJ. Ischemic preconditioning: application in clinical liver transplantation. Liver Transpl 2001; 7: 300-301.
34. Clavien PA, Selzner M, Rudiger HA, et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 2003; 238: 843-850.
35. Bowers BA, Branum GD, Rotolo FS, et al. Bile flow-an index of ischemic injury. J Surg Res 1987; 42: 565-569.
36. Nathanson MH, Boyer JL. Mechanisms and regulation of bile secretion. Hepatology 1991; 14: 551-566.
37. Simon FR, Sutherland E, Accatino L. Stimulation of hepatic sodium and potassium-activated adenosine triphosphatase activity by phenobarbital. Its possible role in regulation of bule flow. J Clin Invest 1977; 59: 849-861.
38. Nakayama H, Yamamoto Y, Kume M, et al. Pharmacologic stimulation of adenosine A2 receptor supplants ischemic preconditioning in providing ischemic tolerance in rat livers. Surgery 1999; 126: 945-954.
39. Howell JG, Zibari GB, Brown MF, et al. Both ischemic and pharmacological preconditioning decrease hepatic leukocyte/endothelial cell interactions. Transplantation 2000; 69: 300-303.
40. Suzuki S, Toledo-Pereyra LH, Rodriguez FJ, et al. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine. Transplantation 1993; 55: 1265-1272.
41. Jaeschke H, Smith CW. Mechanisms of neutrophil-induced parenchymal cell injury. J Leukoc Biol 1997; 61: 647-653.
42. Tomizawa N, Ohwada S, Ohya T, et al. The effect of neutrophil elastase inhibitor in hepatectomy with ischemia in dogs. J Surg Res 1999; 81: 230-237.
43. Vollmar B, Glasz J, Leiderer R, et al. Hepatic microcirculatory perfusion failure is a determinant of liver dysfunction in warm ischemia-reperfusion. Am JPathol 1994; 145: 1421-1431.
44. Koo A, Komatsu H, Tao G, et al. Contribution of no-reflow phenomenon to hepatic injury after ischemia-reperfusion: evidence for a role for superoxide anion. Hepatology 1992; 15: 507-514.
45. Jaeschke H, Reactive oxygen and ischemia/reperfusion injury of the liver. Chem Biol Interact 1991; 79: 115-136.
46. Thiel M, Chambers JD, Chouker A, et al. Effect of adenosine on the expression of beta(2) integrins and L-selectin of human polymorphonuclear leukocytes in vitro. J Leukoc Biol 1996; 59: 671-682.
47. White DA, Wong PW, Downey R. The utility of open lung biopsy in patients with hematologic malignancies. Am J Respir Crit Care Med 2000; 161: 723-729.
48. Ishida T, Yarimizu K, Gute DC, et al. Mechanisms of ischemic preconditioning. Shock 1997; 8: 86-94.
49. Wang NP, Bufkin BL, Nakamura M, et al. Ischemic preconditioning reduces neutrophil accumulation and myocardial apoptosis. Ann Thorac Surg 1999; 67: 1689-1695.
50. Pang CY, Neligan P, Zhong A, et al. Effector mechanism of adenosine in acute ischemic preconditioning of skeletal muscle against infarction. Am J Physiol 1997; 273: R887-R895.
51. Peralta C, Fernandez L, Panes J, et al. Preconditioning protects against systemic disorders associated with hepatic ischemia-reperfusion through blockade of tumor necrosis factor-induced P-selectin up-regulation in the rat. Hepatology 2001; 33: 100-113.
52. Abt PL, Desai NM, Crawford MD, et al. Survival following liver transplantation from non-heart-beating donors. Ann Surg 2004; 239: 87-92.